Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
News|Poll|April 25, 2014
Widespread Blisters in an Older Man
This chronic, autoimmune, subepidermal disease mostly affects older persons. Marked by spontaneous remissions and exacerbations, it manifests with tense blisters that usually start on the arms and legs. Your dx?
Advertisement
This chronic, autoimmune, subepidermal disease mostly affects older persons. Marked by spontaneous remissions and exacerbations, it manifests with tense blisters that usually start on the arms and legs.
Your dx?
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
3
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
4
FAQ: What the Endocrine Society’s New Scientific Statement Means for Obesity Treatment
5